RegDesk
RegDesk is the most comprehensive AI-enabled RIMS platform for Medical Devices, Pharmaceuticals, and IVD companies.
• Our proprietary Regulatory Intelligence for over 120+ countries is translated and accessible in a standard format. In addition, it provides alerts on evolving regulatory changes
• Our AI-powered Application Builder allows RA teams to prepare and publish global applications in 1/10th of the time
• Our Change Assessment capability helps RA teams understand the impact of the change(s) on an existing product(s) and the action required
• Our Distributor Collaboration provides seamless workflow solutions to interact, communicate, and share documents with external business partners
• Our Standards Management makes it easy for RA teams to search and manage not only international but also country-specific standards
• Our Tracking & Reporting functionality allows teams to track regulatory projects across the globe, receive renewal notifications, and generate reports on KPIs within seconds
For more information, visit our website.
Learn more
RunPod
RunPod provides a cloud infrastructure that enables seamless deployment and scaling of AI workloads with GPU-powered pods. By offering access to a wide array of NVIDIA GPUs, such as the A100 and H100, RunPod supports training and deploying machine learning models with minimal latency and high performance. The platform emphasizes ease of use, allowing users to spin up pods in seconds and scale them dynamically to meet demand. With features like autoscaling, real-time analytics, and serverless scaling, RunPod is an ideal solution for startups, academic institutions, and enterprises seeking a flexible, powerful, and affordable platform for AI development and inference.
Learn more
Kanteron
The Kanteron Platform assimilated a wide array of medical images, digital pathology slides, genomic sequences, and patient information from various modalities, scanners, sequencers, and databases, delivering a comprehensive data toolkit to all teams within hospital networks. It emphasizes pharmacogenomics to avert adverse medication events and facilitates the application of precision medicine at the point of care by integrating data sources on drug-gene interactions that were formerly only accessible in less user-friendly formats, such as tables found in PDF documents. By incorporating major pharmacogenomic databases like PharmGKB, CGI, DGIdb, and OpenTargets, it enables users to customize their queries according to specific gene families, types of interactions, and drug classifications. Additionally, its adaptable AI allows users to select the dataset that best aligns with their specific use case, applying it effectively to pertinent medical images. This robust functionality not only enhances the accuracy of medical insights but also fosters a more personalized approach to patient care.
Learn more
NVIDIA Parabricks
NVIDIA® Parabricks® stands out as the sole suite of genomic analysis applications that harnesses GPU acceleration to provide rapid and precise genome and exome analysis for various stakeholders, including sequencing centers, clinical teams, genomics researchers, and developers of high-throughput sequencing instruments. This innovative platform offers GPU-optimized versions of commonly utilized tools by computational biologists and bioinformaticians, leading to notably improved runtimes, enhanced workflow scalability, and reduced computing expenses. Spanning from FastQ files to Variant Call Format (VCF), NVIDIA Parabricks significantly boosts performance across diverse hardware setups featuring NVIDIA A100 Tensor Core GPUs. Researchers in genomics can benefit from accelerated processing throughout their entire analysis workflows, which includes stages such as alignment, sorting, and variant calling. With the deployment of additional GPUs, users can observe nearly linear scaling in computational speed when compared to traditional CPU-only systems, achieving acceleration rates of up to 107X. This remarkable efficiency makes NVIDIA Parabricks an essential tool for anyone involved in genomic analysis.
Learn more